• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Mind Medicine Mindmed Inc (NQ: MNMD )

    8.375 +0.185 (+2.26%)
    Streaming Delayed Price Updated: 3:16 PM EST, Nov 13, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Mind Medicine Mindmed Inc

    < Previous 1 2
    ...
    21 22 23 24 25 26 27 28 29
    ...
    31 32 Next >
    Wellbeing Digital, Small Pharma Among Top Psychedelic Movers Of Today
    GAINERS: Wellbeing Digital (OTC: 
    Via Benzinga
    Seelos Therapeutics, Mind Medicine Among Top Psychedelic Movers Of Today
    GAINERS: Allied (OTC: 
    Via Benzinga
    Psychedelic Stock Gainers And Losers From March 10, 2022
    GAINERS: Revive Therapeutics (OTC: 
    Via Benzinga
    Psychedelic Stock Gainers And Losers From March 9, 2022
    GAINERS: ATAI Life Sciences (NASDAQ: 
    Via Benzinga
    MindMed Converts Shares To Have A Single Class
    Psychedelics-focused biopharma company Mind Medicine Inc. (NASDAQ: 
    Via Benzinga
    Benzinga Expands Footprint into the Psychedelic Industry with the Launch of the Benzinga Psychedelic Advisory Council
    DETROIT, March 4, 2022 /PRNewswire/ -- The Benzinga Psychedelics Advisory Council is a collective of the leading minds and voices in the ... 
    Via Benzinga
    Psychedelic Stock Gainers And Losers From March 7, 2022
    GAINERS: GH Research (NASDAQ: 
    Via Benzinga
    NetworkNewsAudio – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Differentiates Itself in Psychedelics Space
    Via Investor Brand Network
    Psychedelic Stock Gainers And Losers From March 4, 2022
    GAINERS: Wellbeing Digital (OTC: 
    Via Benzinga
    Psychedelic Stock Gainers And Losers From March 3, 2022
    GAINERS: Seelos Therapeutics (NASDAQ: 
    Via Benzinga
    LSD And Magic Mushroom's Active Compound Appear To Have The Same Effects, New Study Finds
    A new peer-reviewed study compared the effects of LSD and psilocybin, two substances currently standing as top molecules behind the recent psychede... 
    Via Benzinga
    Psychedelic Stock Gainers And Losers From March 2, 2022
    GAINERS: Mindset Pharma (OTC: 
    Via Benzinga
    Psychedelic Therapies Offer Hope For Mental Health
    This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.... 
    Via Benzinga
    Psychedelic Therapies Offer Hope for Mental Health
    Via Investor Brand Network
    Psychedelic Therapies Offer Hope for Mental Health
    Via Investor Brand Network
    Psychedelic Therapies Offer Hope for Mental Health
    NetworkNewsWire Editorial Coverage New York, NY – March 2, 2022 – Neural plasticity is instrumental in brain health, and the importance of neuroplasticity can’t be overstated. Indeed, the inability of... 
    Via FinancialNewsMedia
    Psychedelic Stock Gainers And Losers From March 1, 2022
    GAINERS: Cybin (AMEX: 
    Via Benzinga
    Psychedelic Stock Gainers And Losers From February 28, 2022
    GAINERS: Wellbeing Digital (OTC: 
    Via Benzinga
    Psychedelic & Marijuana Drug Stocks Continue To Decline
    This article updates the latest stock performances of the 13 clinical-stage companies with the largest market capitalizations which are tracked in the munKNEE Pure-Play Marijuana (4) and the munKNEE... 
    Via Talk Markets
    Field Trip Health, Seelos Therapeutics Among Top Psychedelic Movers Of Today
    GAINERS: Field Trip Health (NASDAQ: 
    Via Benzinga
    Psychedelic Stock Gainers And Losers From February 24, 2022
    GAINERS: Seelos Therapeutics (NASDAQ: 
    Via Benzinga
    Small Pharma, GH Research Among Top Psychedelic Movers Of Today
    GAINERS: Small Pharma (OTC: 
    Via Benzinga
    Psychedelic Stock Gainers And Losers From February 22, 2022
    GAINERS: LOSERS: Mindset Pharma (OTC: 
    Via Benzinga
    Psychedelic & Marijuana Drug Stocks Continued To Decline Last Week
    An update on the stock performances of the 13 clinical-stage psychedelic and marijuana drug companies with the largest market capitalizations.tttttttttt 
    Via Talk Markets
    Field Trip Health, Mind Medicine Among Top Psychedelic Movers Of Today
    GAINERS: Field Trip Health (NASDAQ: 
    Via Benzinga
    Psychedelic Stock Gainers And Losers From February 17, 2022
    GAINERS: Mindset Pharma (OTC: 
    Via Benzinga
    Cybin, Deepak Chopra Announce Partnership For Psychedelics Awareness And Education
    Psychedelics-focused biotech company Cybin Inc. (NYSE:CYBN) ... 
    Via Benzinga
    Psychedelic Stock Gainers And Losers From February 15, 2022
    GAINERS: Mind Medicine (NASDAQ: 
    Via Benzinga
    Psychedelic Stock Gainers And Losers From February 14, 2022
    GAINERS: Wellbeing Digital (OTC: 
    Via Benzinga
    Psychedelic And Cannabis Drug Stocks Continue Advance
    This article updates the performances of 16 clinical-stage psychedelic and marijuana drug companies researching the treatment of a wide variety of mental illnesses. 
    Via Talk Markets
    < Previous 1 2
    ...
    21 22 23 24 25 26 27 28 29
    ...
    31 32 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.